betaxolol and Exfoliation Glaucoma studies

betaxolol and Exfoliation Glaucoma

betaxolol has been researched along with Exfoliation Glaucoma in 2 studies

Research Excerpts

Excerpt	Relevance	Reference
" The side effect profile of unoprostone appears to be comparable to other established IOP-lowering agents."	6.70	A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. ( Kapik, B; Mertz, B; Nordmann, JP; Schwenninger, C; Shams, N; Yannoulis, NC, 2002)
" The side effect profile of unoprostone appears to be comparable to other established IOP-lowering agents."	2.70	A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. ( Kapik, B; Mertz, B; Nordmann, JP; Schwenninger, C; Shams, N; Yannoulis, NC, 2002)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Heijl, A	1
Peters, D	1
Leske, MC	1
Bengtsson, B	1
Nordmann, JP	1
Mertz, B	1
Yannoulis, NC	1
Schwenninger, C	1
Kapik, B	1
Shams, N	1

Studies

Heijl, A

Peters, D

Leske, MC

Bengtsson, B

Nordmann, JP

Mertz, B

Yannoulis, NC

Schwenninger, C

Kapik, B

Shams, N

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
[NCT00000132]	Phase 3	0 participants	Interventional	1992-10-31	Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

[NCT00000132]

Phase 3

0 participants

Interventional

1992-10-31

Active, not recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for betaxolol and Exfoliation Glaucoma

Article	Year
Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial. American journal of ophthalmology, 2011, Volume: 152, Issue:5 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Cohort Studies; Disease Progression; Exfoli	2011
A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. American journal of ophthalmology, 2002, Volume: 133, Issue:1 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Dinoprost; Double-Blind Method; Exf	2002

Article

Year

Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.

American journal of ophthalmology, 2011, Volume: 152, Issue:5

Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Cohort Studies; Disease Progression; Exfoli

2011

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.

American journal of ophthalmology, 2002, Volume: 133, Issue:1

Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Dinoprost; Double-Blind Method; Exf

2002